Burkhardt, Immo et al. published their research in Organic & Biomolecular Chemistry in 2017 |CAS: 168297-86-7

The Article related to ruegeria dmsp lyase isoenzyme recognition substrate analog preparation kinetics, Enzymes: Substrates-Cofactors-Inhibitors-Activators-Coenzymes-Products and other aspects.Computed Properties of 168297-86-7

Burkhardt, Immo; Lauterbach, Lukas; Brock, Nelson L.; Dickschat, Jeroen S. published an article in 2017, the title of the article was Chemical differentiation of three DMSP lyases from the marine Roseobacter group.Computed Properties of 168297-86-7 And the article contains the following content:

Dimethylsulfoniopropionate (DMSP) catabolism of marine bacteria plays an important role in marine and global ecol. The genome of Ruegeria pomeroyi DSS-3, a model organism from the Roseobacter group, harbors no less than three genes for different DMSP lyases (DddW, DddP and DddQ) that catalyze the degradation of DMSP to di-Me sulfide (DMS) and acrylate. Despite their apparent similar function these enzymes show no significant overall sequence identity. In this work DddQ and DddW from R. pomeroyi and the DddP homolog from Phaeobacter inhibens DSM 17395 were functionally characterized and their substrate scope was tested using several synthetic DMSP analogs. Comparative kinetic assays revealed differences in the conversion of DMSP and its analogs in terms of selectivity and overall velocity, giving addnl. insights into the mol. mechanisms of DMSP lyases and into their putatively different biol. functions. The experimental process involved the reaction of (S)-4-Isopropyl-5,5-dimethyloxazolidin-2-one(cas: 168297-86-7).Computed Properties of 168297-86-7

The Article related to ruegeria dmsp lyase isoenzyme recognition substrate analog preparation kinetics, Enzymes: Substrates-Cofactors-Inhibitors-Activators-Coenzymes-Products and other aspects.Computed Properties of 168297-86-7

Referemce:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Madar, D. J. et al. published their research in Tetrahedron Letters in 2001 |CAS: 97859-49-9

The Article related to arylated oxazolidinone preparation, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.HPLC of Formula: 97859-49-9

On May 28, 2001, Madar, D. J.; Kopecka, H.; Pireh, D.; Pease, J.; Pliushchev, M.; Sciotti, R. J.; Wiedeman, P. E.; Djuric, S. W. published an article.HPLC of Formula: 97859-49-9 The title of the article was Synthesis of N-arylated oxazolidinones via a palladium catalyzed cross coupling reaction. Application to the synthesis of the antibacterial agent Dup-721. And the article contained the following:

A method for the intermol. coupling of aryl bromides and oxazolidinones is described. Application to intermediates useful for the preparation of a known class of antibacterial agent and the synthesis of the known antibacterial oxazolidinone Dup-721 are described. The experimental process involved the reaction of (R)-5-(Hydroxymethyl)oxazolidin-2-one(cas: 97859-49-9).HPLC of Formula: 97859-49-9

The Article related to arylated oxazolidinone preparation, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.HPLC of Formula: 97859-49-9

Referemce:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Peer Mohamed, Shahul Hameed et al. published their patent in 2019 |CAS: 97859-49-9

The Article related to oxazolidinone preparation antibiotic, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Application of 97859-49-9

On October 4, 2019, Peer Mohamed, Shahul Hameed; Bharatham, Nagakumar; Katagihallimath, Nainesh; Sharma, Sreevalli; Nandishaiah, Radha; Ramachandran, Vasanthi published a patent.Application of 97859-49-9 The title of the patent was Oxazolidinone compounds as antibiotics and process of preparation. And the patent contained the following:

The disclosure relates to compounds of formula I, its stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms and pharmaceutically active derivative thereof and pharmaceutical compositions containing them as the active ingredient which can be used as medicaments. The aforementioned substances can also be used in the manufacture of medicaments for treatment, prevention, or suppression of diseases, and conditions mediated by microbes. The disclosure also relates to the synthesis and characterization of aforementioned substances. Compounds of formula I wherein A is absent and CH2; B is CH2 and CH2CH2; X1 is N and CR4; X2 is N and CR5; Y1 and Y2 are independently N and CR7; Z1 is O, S, NH and CH2; R1 is (un)substituted C1-6 alkyl, (un)substituted C2-6 alkenyl, (un)substituted C3-6 cycloalkyl, etc.; R2 is H, halo, OH, CN, C1-6 alkoxy, etc.; R3 is H, F, C1-4 alkoxy, etc.; R4 is H, C1-4 alkoxy, C1-6 haloalkyl, etc.; R5 is H, CN, (un)substituted C1-6 alkyl, CO2H, etc.; R6 is H, C1-6 alkyl and C1-6 alkoxy; R7 is H, halo, CN, C1-6 alkoxy, etc.; and stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms and pharmaceutically active derivatives thereof, are claimed. Example compound II was prepared by reductive alkylation of 6-(5-(2-aminoethyl)-2-oxooxazolidin-3-yl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one with 2-(4-methyl-3,6-dioxo-4,6-dihydropyrido[2,3-b]pyrazin-5(3H)-yl)acetaldehyde. The invention compounds were evaluated for their antibacterial activity. From the assay, it was determined that compound II exhibited MIC values in the range of 0.06μg/mL to 0.5μg/mL. The experimental process involved the reaction of (R)-5-(Hydroxymethyl)oxazolidin-2-one(cas: 97859-49-9).Application of 97859-49-9

The Article related to oxazolidinone preparation antibiotic, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Application of 97859-49-9

Referemce:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Peer Mohamed, Shahul Hameed et al. published their patent in 2019 |CAS: 97859-49-9

The Article related to oxazolidinone preparation antibiotic, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Electric Literature of 97859-49-9

On October 3, 2019, Peer Mohamed, Shahul Hameed; Bharatham, Nagakumar; Katagihallimath, Nainesh; Sharma, Sreevalli; Nandishaiah, Radha; Ramachandran, Vasanthi published a patent.Electric Literature of 97859-49-9 The title of the patent was Oxazolidinone compounds as antibiotics and process of preparation. And the patent contained the following:

The disclosure relates to compounds of formula I, its stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms and pharmaceutically active derivative thereof and pharmaceutical compositions containing them as the active ingredient which can be used as medicaments. The aforementioned substances can also be used in the manufacture of medicaments for treatment, prevention, or suppression of diseases, and conditions mediated by microbes. The disclosure also relates to the synthesis and characterization of aforementioned substances. Compounds of formula I wherein A is absent and CH2; B is CH2 and CH2CH2; X1 is N and CR4; X2 is N and CR5; Y1 and Y2 are independently N and CR7; Z1 is O, S, NH and CH2; R1 is (un)substituted C1-6 alkyl, (un)substituted C2-6 alkenyl, (un)substituted C3-6 cycloalkyl, etc.; R2 is H, halo, OH, CN, C1-6 alkoxy, etc.; R3 is H, F, C1-4 alkoxy, etc.; R4 is H, C1-4 alkoxy, C1-6 haloalkyl, etc.; R5 is H, CN, (un)substituted C1-6 alkyl, CO2H, etc.; R6 is H, C1-6 alkyl and C1-6 alkoxy; R7 is H, halo, CN, C1-6 alkoxy, etc.; and stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms and pharmaceutically active derivatives thereof, are claimed. Example compound II was prepared by reductive alkylation of 6-(5-(2-aminoethyl)-2-oxooxazolidin-3-yl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one with 2-(4-methyl-3,6-dioxo-4,6-dihydropyrido[2,3-b]pyrazin-5(3H)-yl)acetaldehyde. The invention compounds were evaluated for their antibacterial activity. From the assay, it was determined that compound II exhibited MIC values in the range of 0.06μg/mL to 0.5μg/mL. The experimental process involved the reaction of (R)-5-(Hydroxymethyl)oxazolidin-2-one(cas: 97859-49-9).Electric Literature of 97859-49-9

The Article related to oxazolidinone preparation antibiotic, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Electric Literature of 97859-49-9

Referemce:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Gordeev, Mikhail F. et al. published their patent in 2001 |CAS: 97859-49-9

The Article related to oxazolidinone preparation bactericide, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Formula: C4H7NO3

On May 29, 2001, Gordeev, Mikhail F.; Luehr, Gary W.; Patel, Dinesh V.; Ni, Zhi-jie; Gordon, Eric published a patent.Formula: C4H7NO3 The title of the patent was Preparation of oxazolidinones as bactericides. And the patent contained the following:

Title compounds [e.g., I; R = H; R1 = SR11, CONR7R8, etc.; R7,R8,R11 = H, alkyl, (hetero)aryl, etc.] were prepared Thus, 3,4-F(Me3CO2C)C6H3NHCO2CH2Ph (preparation given) was cyclocondensed with (R)-glycidyl butyrate and the product converted in several steps to I (R = resin, R1 = CO2C6F5) which was amidated by morpholine to give, after resin cleavage, I (R = H, R1 = CONHR8, R8 = morpholino). Data for biol. activity of I were given. The experimental process involved the reaction of (R)-5-(Hydroxymethyl)oxazolidin-2-one(cas: 97859-49-9).Formula: C4H7NO3

The Article related to oxazolidinone preparation bactericide, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Formula: C4H7NO3

Referemce:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Hagen, Susan Elizabeth et al. published their patent in 2005 |CAS: 97859-49-9

The Article related to antibacterial agent quinolone preparation, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Recommanded Product: (R)-5-(Hydroxymethyl)oxazolidin-2-one

On March 24, 2005, Hagen, Susan Elizabeth; Josyula, Vara Prasad Venkata Nagendra published a patent.Recommanded Product: (R)-5-(Hydroxymethyl)oxazolidin-2-one The title of the patent was Preparation of substituted quinolones and derivatives thereof as antibacterial agents. And the patent contained the following:

Title compounds I [Z2 = aminocarbonyl, carbonylamino, CN; either D = N, E = C, F = CH or D = CH, E = N, F = CH2 if — is absent; J, K, Q = (un)substituted alkyl, N with provisions; n = 0-2; at least one of W, X, Y = NP; P = substituted quinolone] are prepared For instance, II is prepared from 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid boron difluoride chelate and N-[2-oxo-3-(2,3,4,5-tetrahydro-1H-benzo[c]azepin-7-yl)oxazolidin-5-ylmethyl]acetamide to give an intermediate borate ester which is converted to the final product upon treatment with Et3N, water at reflux for 18 h. II has MIC 1 μg/mL against E. Faecalis and 0.06 μg/mL against S. aureus. I are useful for the treatment of bacterial infections. The experimental process involved the reaction of (R)-5-(Hydroxymethyl)oxazolidin-2-one(cas: 97859-49-9).Recommanded Product: (R)-5-(Hydroxymethyl)oxazolidin-2-one

The Article related to antibacterial agent quinolone preparation, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Recommanded Product: (R)-5-(Hydroxymethyl)oxazolidin-2-one

Referemce:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Danielmeier, Karsten et al. published their research in Tetrahedron: Asymmetry in 1995 |CAS: 97859-49-9

The Article related to oxazolidinone derivative enantiomerically pure, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Quality Control of (R)-5-(Hydroxymethyl)oxazolidin-2-one

On May 31, 1995, Danielmeier, Karsten; Steckhan, Eberhard published an article.Quality Control of (R)-5-(Hydroxymethyl)oxazolidin-2-one The title of the article was Efficient pathways to (R)- and (S)-5-hydroxymethyl-2-oxazolidinone and some derivatives. And the article contained the following:

Two new syntheses of enantiomerically pure (R)- and (S)-5-hydroxymethyl-2-oxazolidinone have been developed starting with D-mannitol, L-ascorbic acid and (R)- or (S)-malic acid. (R)- and (S)-5-hydroxymethyl-2-oxazolidinone have been used to synthesize some new homochiral 2-oxazolidinone derivatives The experimental process involved the reaction of (R)-5-(Hydroxymethyl)oxazolidin-2-one(cas: 97859-49-9).Quality Control of (R)-5-(Hydroxymethyl)oxazolidin-2-one

The Article related to oxazolidinone derivative enantiomerically pure, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Quality Control of (R)-5-(Hydroxymethyl)oxazolidin-2-one

Referemce:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Bew, Sean P. et al. published their research in Chirality in 2000 |CAS: 168297-86-7

The Article related to acetoxy acid chloride kinetic resolution superquat, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.COA of Formula: C8H15NO2

On June 30, 2000, Bew, Sean P.; Davies, Stephen G.; Fukuzawa, Shin-Ichi published an article.COA of Formula: C8H15NO2 The title of the article was Kinetic resolution of α-acetoxy carboxylic acids with homochiral SuperQuats. And the article contained the following:

Preliminary investigations focused on the kinetic resolution of (±)-O-acetyl mandelic acid chloride with iso-Pr SuperQuat and iso-Pr Evans’ homochiral auxiliaries. The addition of 2 equiv of the acid chloride to the lithium salts of the auxiliaries (SuperQuat and Evans’) at -100° in THF afforded the N-acyl auxiliaries in high chem. yields (95 and 89%) and d.e.’s of 66 and 40%, resp. Using the same mandelic acid chloride but incorporating SuperQuat auxiliaries derived from (S)-phenylglycine and (S)-phenylalanine gave the N-acyl SuperQuats in 86 and 90% yield and d.e.’s of 66 and 30%, resp. Replacing the Ph group in the O-acetyl mandelic acid chloride with a Bu, tert-Bu, or cyclohexyl group changed the d.e. significantly when kinetically resolved with iso-Pr SuperQuat. The yields were all similar, i.e., ∼90%, but the d.e.’s varied considerably, with values of 20, 50, and 82%, resp. Attempted kinetic resolution of α-methoxy-phenylacetyl chloride using the lithium salt of iso-Pr SuperQuat revealed a diastereoselectivity of 45%, significantly lower than that obtained with the corresponding α-acetoxy carboxylic acid chlorides. The experimental process involved the reaction of (S)-4-Isopropyl-5,5-dimethyloxazolidin-2-one(cas: 168297-86-7).COA of Formula: C8H15NO2

The Article related to acetoxy acid chloride kinetic resolution superquat, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.COA of Formula: C8H15NO2

Referemce:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Sciotti, Richard J. et al. published their research in Bioorganic & Medicinal Chemistry Letters in 2002 |CAS: 97859-49-9

The Article related to antimicrobial oxazolidinone compound preparation biol evaluation, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Reference of (R)-5-(Hydroxymethyl)oxazolidin-2-one

On August 19, 2002, Sciotti, Richard J.; Pliushchev, Marina; Wiedeman, Paul E.; Balli, Darlene; Flamm, Robert; Nilius, Angela M.; Marsh, Kennan; Stolarik, DeAnne; Jolly, Robert; Ulrich, Roger; Djuric, Stevan W. published an article.Reference of (R)-5-(Hydroxymethyl)oxazolidin-2-one The title of the article was The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class. And the article contained the following:

A novel series of antimicrobials of the oxazolidinone class is disclosed. These compounds are characterized relative to previously described analogs by a ‘halostilbene-derived’ pharmacophore and demonstrate enhanced antimicrobial activity against key Gram-pos. pathogens when compared to Linezolid. The experimental process involved the reaction of (R)-5-(Hydroxymethyl)oxazolidin-2-one(cas: 97859-49-9).Reference of (R)-5-(Hydroxymethyl)oxazolidin-2-one

The Article related to antimicrobial oxazolidinone compound preparation biol evaluation, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Reference of (R)-5-(Hydroxymethyl)oxazolidin-2-one

Referemce:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem

 

Ortiz, Aurelio et al. published their research in Tetrahedron Letters in 2003 |CAS: 168297-86-7

The Article related to oxazolidinethione preparation reactivity, crystal structure oxazolidinethione derivative, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Recommanded Product: 168297-86-7

On February 3, 2003, Ortiz, Aurelio; Quintero, Leticia; Hernandez, Hector; Maldonado, Sotero; Mendoza, Guadalupe; Bernes, Sylvain published an article.Recommanded Product: 168297-86-7 The title of the article was (S)-4-Isopropyl-5,5-dimethyl-1,3-oxazolidinethione as chiral auxiliary for the intramolecular sulfur transfer in α,β-unsaturated N-acylimides, promoted by NbCl5. And the article contained the following:

The 1,3-oxazolidinethione was synthesized from (S)-valine and used in the intramol. S transfer in its N-enoyl derivatives in the presence of NbCl5 as catalyst, which, also, works as an indicator of the reaction. The adducts have subsequently been transformed into the corresponding β-mercapto esters by action of Sm(OTf)3 in MeOH. The experimental process involved the reaction of (S)-4-Isopropyl-5,5-dimethyloxazolidin-2-one(cas: 168297-86-7).Recommanded Product: 168297-86-7

The Article related to oxazolidinethione preparation reactivity, crystal structure oxazolidinethione derivative, Heterocyclic Compounds (More Than One Hetero Atom): Oxazoles, Isoxazoles and other aspects.Recommanded Product: 168297-86-7

Referemce:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem